Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.70 |
| ▸ | ASPH | Q12797 | 3/20 | 0.70 |
| ▸ | KDM8 | Q8N371 | 2/20 | 0.70 |
| ▸ | KMO | O15229 | 8/20 | 0.47 |
| ▸ | P4HTM | Q9NXG6 | 5/20 | 0.43 |
| ▸ | P4HA1 | P13674 | 1/20 | 0.43 |
| ▸ | MIF | P14174 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | KDM6B | O15054 | 1/20 | 0.42 |
| ▸ | TET3 | O43151 | 1/20 | 0.42 |
| ▸ | KDM4A | O75164 | 1/20 | 0.42 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KDM5A | P29375 | 1/20 | 0.42 |
| ▸ | KDM5C | P41229 | 1/20 | 0.42 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.42 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.42 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.42 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.42 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31474566 | 0.98 | KDM4E (0.68) | KDM4EASPHKDM8KMOP4HTM | |
| SCHEMBL31220823 | 0.83 | KDM4E (0.66) | KDM4EASPHKDM8KMOP4HTM | |
| SCHEMBL21989487 | 0.81 | KDM4E (0.63) | KDM4EASPHKDM8KMOP4HTM | |
| SCHEMBL21633969 | 0.81 | KDM4E (0.63) | KDM4EASPHKDM8KMOP4HTM | |
| SCHEMBL31032199 | 0.79 | KDM4E (0.61) | KDM4EASPHKDM8KMOP4HTM | |
| SCHEMBL12235269 | 0.78 | KDM4E (0.59) | KDM4EASPHKDM8KMOP4HTM | |
| SCHEMBL29272367 | 0.78 | ASPH (0.64) | KDM4EASPHKDM8KMOP4HTM | |
| SCHEMBL27164886 | 0.77 | KDM4E (0.53) | KDM4EASPHKDM8KMOP4HTM | |
| SCHEMBL29011990 | 0.77 | KDM4E (0.58) | KDM4EASPHKDM8KMOP4HTM | |
| SCHEMBL26120504 | 0.74 | KMO (0.51) | KDM4EASPHKDM8KMOP4HTM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4572759-A2 | THIAZOLE DERIVATIVES FOR THERAPEUTIC USE | Nimml Institute (US) | 2025-06-25 | — | — | EP | disclosed |
| US-20240076296-A1 | THIAZOLE DERIVATIVES FOR THERAPEUTIC USE | NIMML INSTITUTE (US) | 2024-03-07 | — | — | US | disclosed |
| WO-2024040259-A2 | THIAZOLE DERIVATIVES FOR THERAPEUTIC USE | NIMML INSTITUTE (US) | 2024-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240076296-A1 | THIAZOLE DERIVATIVES FOR THERAPEUTIC USE | CD4, IFNG, IL2 | KDM4E 4061/4885ASPH 3785/4885KDM8 4729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.